Developer docs
API playgroundTry for free, no card

Search company profiles

Advanced Molecular Technologies

Full company profile

uuid002l3uc

Namestring
Advanced Molecular Technologies
Legal namestring
Advanced Molecular Technologies Pty Ltd
Websiteurl
amtechpl.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Advanced Molecular Technologies Pty Ltd (AMT) is an Australian privately held contract research organisation (CRO) and specialty chemical manufacturer headquartered in Scoresby, Victoria, founded in 2005. The company operates a 1-10 person laboratory focused on medicinal chemistry, custom organic synthesis, and a broad catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, halogenated organics, diaryls, catalysts, bioactives, PEG reagents and linkers, and fluorophores and dyes. Core service offerings comprise custom synthesis (route design, target molecule synthesis, structure-based drug design, metabolite and impurity synthesis, GLP-compliant production for in vivo studies) and fee-for-service analytical chemistry using a Bruker Avance III 400 MHz NMR, Waters HPLC, PerkinElmer GC, Agilent FT-IR, and supporting instrumentation. AMT also incubates proprietary biotech programmes in organoboron pharmaceuticals and diagnostics, PEG linkers for antibody-drug conjugates, and AMPK activators.

AMT makes money through three distinct streams: (i) professional-service custom synthesis contracts with pharmaceutical, biotech, agricultural, and academic clients, (ii) one-time catalogue chemical product sales at unit prices typically ranging from approximately AUD $80 to $780 per pack, and (iii) usage-based analytical service fees starting at AUD $25 per 1H NMR sample. The company employs a sales-led direct go-to-market via its website, phone, and email, supplemented by an international channel partner network: Frontier Specialty Chemicals distributes AMT PEG products in the US (announced November 2025), Key Organics holds an exclusive European supply and marketing agreement under the BIONET brand (since September 2013), IDT Australia provides GMP manufacturing collaboration for clinical and commercial PEG linker supply (since December 2023), and Scaled Organics and AK Scientific act as additional distribution partners. End customers include pharmaceutical and biotechnology companies (primary segments), agricultural chemical firms, and academic and research institutions across Australia, North America, Europe, and Japan.

Short descriptiontext

Advanced Molecular Technologies (AMT) is a privately held Australian CRO and specialty chemical manufacturer offering custom organic synthesis, analytical services, and a catalogue of organoborons, PEG linkers, fluorophores, and ionisable lipids to pharmaceutical, biotech, agricultural, and academic clients globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersScoresby, Australia
HQ citystring
Scoresby
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
custom organic synthesis, medicinal chemistry services, specialty chemicals manufacturing, PEG linkers bioconjugation, analytical chemistry services
Industry2 codes
PRIMARYHLAGAHAH
Custom Intermediates & Advanced Intermediates Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Testing Laboratories and Services541380
  • Other Scientific and Technical Consulting Services541690
  • Medical and Diagnostic Laboratories62151
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
  • Miscellaneous Chemical Products2890
Product category
Contract Research Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Custom Synthesis Contracts
TypeProfessional Services
Description

AMT provides contract research and custom synthesis services to pharmaceutical, biotech, agricultural and academic institutions. Services include route design, target molecule synthesis, drug discovery, and process scale-up.

amtechpl.com
2Catalogue Chemical Product Sales
TypeOne Time License
Description

Sale of in-stock specialty chemicals including organoborons, organosilicons, nucleosides, halogenated organics, diaryls, catalysts, bioactives, PEG reagents and linkers, and fluorophores and dyes. Products are sold in various pack sizes with unit-based pricing.

amtechpl.com
3Analytical Services
TypeTransaction Fee
Description

Fee-for-service analytical testing including NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, Polarimetry, DSC, Flash Point, and Biotage Flash Purification. Samples from $25.00 AUD per 1H NMR.

amtechpl.com
4GMP Manufacturing Services
TypeManaged Services
Description

Through collaboration with IDT Australia, AMT supports the development and GMP manufacturing of polyethylene glycol (PEG) linkers for clinical and commercial supply.

amtechpl.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details2 tiers
1Unit pricing for catalogue chemical products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Lipid 5 (AMTGC1533-LP25): 500mg $390.00, 1g $595.00; ALC-0315 (AMTGC903-AL21): 500mg $310, 1g $470; Pomalidomide 4'-PEG3-azide (AMTGC1223-PL23): 100mg $120.00, 500mg $360.00; N3-PEG23-CH2CH2NH2 (AMTGC1264-AH24): 100mg $250, 1g $780; SM-102 (AMTGC936-SM21): 500mg $420, 1g $680; 11-Azido-3,6,9-trioxaundecan-1-amine (AMTGC125-AT15): 5g $80, 25g $202; Desthiobiotin-PEG3-Azide (AMTGC1441-DB25): 10mg $120, 25mg $210

amtechpl.com
2NMR analytical service pricing
ModelUsage-basedBilling cadencePay-as-you-go
Notes

NMR Samples (1-9): From $25.00 AUD per sample / 1H NMR (raw data). Samples (10+): Reduced rates available. Processing, interpretation and additional NMR analytical services available.

amtechpl.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Advanced Molecular Technologies (AMT) is a contract research organisation and biotech incubator specialising in medicinal chemistry and custom organic synthesis. The company provides custom synthesis of target molecules, analytical chemistry testing services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC), and a catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, PEG linkers for ADCs, and fluorophores for pharmaceutical, biotech, agricultural and academic customers. AMT also supports GMP manufacturing of PEG linkers for clinical and commercial supply through its collaboration with IDT Australia.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Advanced Molecular Technologies (AMT) operates as a biotech incubator and contract research organization (CRO) specializing in medicinal chemistry and custom organic synthesis. The company's portfolio combines core service offerings with a comprehensive catalog of specialty chemical products. Core services include Custom Organic Synthesis (route design, target molecule synthesis, GLP production for in vivo studies) and Analytical Services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC, flash point testing). The product catalog spans multiple chemical categories: General Chemicals, Organoborons, Organosilicons, Nucleosides, Halogenated Organics, Diaryls, Catalysts, Bioactives, PEG Reagents and Linkers (critical for antibody-drug conjugates and bioconjugate technologies), and Fluorophores and Dyes. AMT also incubates organoboron pharmaceuticals, diagnostics, PEG linkers for ADCs, and AMPK activators. Featured products include ionisable lipids such as Lipid 5, ALC-0315, and SM-102 used in advanced therapeutic modalities.

Product and service16 records
1Custom Organic Synthesis Services
CategoryContract Research Services
Description

Contract research service for custom synthesis of target molecules for pharmaceutical, biotech, and chemical markets. Includes route design, traditional synthesis of complex molecules, production of pharmacologically active reference compounds, structure-based drug design, scaffolds, building blocks, lead optimisation, and synthesis of metabolites, impurities and reference compounds, plus GLP-compliant compounds for in vivo studies.

2Analytical Services
CategoryAnalytical Services
Description

Fee-for-service analytical chemistry testing including NMR (1H, 13C, 10B, 15N, 19F, 29Si, 31P), HPLC (NP/RP, chiral and achiral), GC, FT-IR, UV-Vis, Karl Fischer titration, Polarimetry, Thermogravimetric Analysis, DSC, Closed Cup Flash Point Testing, and Biotage SP4 Flash Purification. Targeted at pharmaceutical, biotech, academic and chemical industry customers.

3GMP Manufacturing of PEG Linkers
CategoryContract Manufacturing Services
Description

Managed-service GMP manufacturing collaboration with IDT Australia for development and production of polyethylene glycol (PEG) linkers. AMT contributes linker chemistry expertise, custom synthesis, process development and scale-up; IDT Australia provides GMP manufacturing, analytical testing, quality systems and regulatory support for clinical and commercial supply. Targeted at ADC developers across North America, Japan and other global pharmaceutical markets.

4General Chemicals Catalogue
CategorySpecialty Chemicals
Description

Broad catalogue of general chemical compounds available for research and industrial applications, sold in various pack sizes with unit-based pricing.

5Organoborons Catalogue
CategorySpecialty Chemicals
Description

Catalogue of organoboron compounds used in cross-coupling reactions and pharmaceutical research, sold in catalogue pack sizes (mg to g) with unit pricing.

6Organosilicons Catalogue
CategorySpecialty Chemicals
Description

Catalogue of organosilicon compounds including HOMSi reagents for Hiyama cross-coupling reactions, sold with unit-based pricing.

7Nucleosides Catalogue
CategorySpecialty Chemicals
Description

Catalogue of nucleoside compounds for pharmaceutical and biotech research applications, sold with unit-based pricing.

8PEG Reagents and Linkers Catalogue
CategorySpecialty Chemicals
Description

Catalogue of polyethylene glycol (PEG) reagents and linkers for antibody-drug conjugates (ADCs), peptide conjugates, and bioconjugate technologies, available in catalogue and bulk quantities including GMP quality materials.

9Fluorophores and Dyes Catalogue
CategorySpecialty Chemicals
Description

Catalogue of fluorescent probes and dyes for research and diagnostic applications, including products such as DBD-F (4-(N,N-Dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole).

10Bioactives Catalogue
CategorySpecialty Chemicals
Description

Catalogue of biologically active compounds for pharmaceutical and biotech research, sold with unit-based pricing.

11Halogenated Organics Catalogue
CategorySpecialty Chemicals
Description

Catalogue of halogenated organic compounds for synthesis and research applications, sold with unit-based pricing.

12Diaryls Catalogue
CategorySpecialty Chemicals
Description

Catalogue of diaryl compounds for pharmaceutical and chemical research, sold with unit-based pricing.

13Catalysts Catalogue
CategorySpecialty Chemicals
Description

Catalogue of catalytic compounds for organic synthesis reactions, sold with unit-based pricing.

14ALC-0315 (AMTGC903-AL21)
CategorySpecialty Chemicals
Description

Featured ionisable lipid compound sold in 500mg ($310 AUD) and 1g ($470 AUD) pack sizes, used in lipid nanoparticle formulations for advanced therapeutics.

15Lipid 5 (AMTGC1533-LP25)
CategorySpecialty Chemicals
Description

Featured ionisable lipid compound sold in 500mg ($390.00 AUD) and 1g ($595.00 AUD) pack sizes, used in lipid nanoparticle formulations for advanced therapeutics.

16SM-102 (AMTGC936-SM21)
CategorySpecialty Chemicals
Description

Featured ionisable lipid compound for pharmaceutical applications, sold in 500mg ($420 AUD) and 1g ($680 AUD) pack sizes.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-20
Description

Distribution partnership with Frontier Specialty Chemicals to enhance customer access to AMT's portfolio of high-purity functionalised PEGs for customers across the US. Frontier serves as a distribution and customer support partner, providing local sales, order management, and customer service. Inventory is located in the US to avoid customs delays. Products are available in catalogue and bulk quantities, as well as GMP quality materials.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-22
Description

Collaboration with IDT Australia to provide a streamlined pathway for the development and GMP manufacturing of polyethylene glycol (PEG) linkers. AMT contributes expertise in linker chemistry, custom synthesis, process development, and scale-up. IDT Australia provides GMP manufacturing capabilities, analytical testing, quality systems, and regulatory support for clinical and commercial supply. The collaboration supports customers across North America, Japan, and other global pharmaceutical markets.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2013-09-02
Description

Exclusive European supply and marketing agreement. Key Organics distributes AMT products under its BIONET brand. Key Organics has an extensive range of over 65,000 screening compounds, intermediates, building blocks and biochemicals and access to global customer base within the global life sciences sector. Both companies collaborate to grow their differentiated technology and service offerings.

4Scaled Organics
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a distribution partner on AMT's partners page. Scaled Organics is a custom synthesis and chemical supply company.

amtechpl.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a distribution partner on AMT's partners page. AK Scientific is a custom synthesis and chemical supply company.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Ukraine-based global supplier of building blocks, screening compounds, and custom synthesis services with a catalogue exceeding 250,000 compounds. Directly comparable to AMT as a catalogue-plus-custom-synthesis CRO serving pharma and academic customers.

TypeDirect peer
Description

China-based supplier of building blocks, intermediates, and custom synthesis services. Comparable to AMT as a custom synthesis CRO with an extensive catalogue, focused on pharma and biotech drug discovery customers.

3Alfa Aesar (Thermo Fisher Scientific)
TypeBroad incumbent
Description

Global catalogue supplier of research chemicals, metals, and materials under Thermo Fisher Scientific. Overlaps with AMT's catalogue offerings (organics, building blocks, specialty chemicals) and serves the same pharma/biotech/academic customer base.

TypeDirect peer
Description

China-headquartered provider of building blocks, intermediates, custom synthesis, and process R&D services to the pharmaceutical industry. Comparable to AMT across custom synthesis, building blocks, and reference compounds, with greater scale and GMP capacity.

TypeBroad incumbent
Description

Global incumbent in research chemicals, analytical standards, and life science products. Overlaps with AMT's catalogue chemical business and analytical reagents, but at vastly greater scale and breadth across all research chemistries.

TypeDirect peer
Description

US-based manufacturer and distributor of specialty organic chemicals, including fluorinated compounds, organometallics, and building blocks. Comparable to AMT as a catalogue chemistry supplier serving pharma, biotech, and academic customers.

TypeDirect peer
Description

US-based supplier of chemical building blocks, screening compounds, and custom synthesis services for drug discovery. Directly comparable to AMT across catalogue building blocks, custom synthesis, and CRO services for pharmaceutical/biotech customers.

8Tokyo Chemical Industry (TCI)
TypeBroad incumbent
Description

Japan-based global supplier of organic chemicals, reagents, and custom synthesis services. Comparable to AMT across organics, organometallics, and catalogue chemistry, with a far larger catalogue and established international distribution.

9Key Organics
TypeDirect peer
Description

UK-based supplier of screening compounds, building blocks, intermediates, and biochemicals (65,000+ compounds under BIONET brand). Directly comparable as a catalogue chemistry and custom synthesis peer, and additionally serves as AMT's exclusive European distribution partner.

TypeEmerging player
Description

US-based specialty chemicals distributor with focused PEG/bioconjugation product line. Comparable to AMT as a PEG-focused supplier to pharma/biotech, and additionally serves as AMT's US distribution partner for PEG products.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Advanced Molecular Technologies

Contract Research Servicesamtechpl.com

Advanced Molecular Technologies (AMT) is a privately held Australian CRO and specialty chemical manufacturer offering custom organic synthesis, analytical services, and a catalogue of organoborons, PEG linkers, fluorophores, and ionisable lipids to pharmaceutical, biotech, agricultural, and academic clients globally.

What Advanced Molecular Technologies does

Advanced Molecular Technologies Pty Ltd (AMT) is an Australian privately held contract research organisation (CRO) and specialty chemical manufacturer headquartered in Scoresby, Victoria, founded in 2005. The company operates a 1-10 person laboratory focused on medicinal chemistry, custom organic synthesis, and a broad catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, halogenated organics, diaryls, catalysts, bioactives, PEG reagents and linkers, and fluorophores and dyes. Core service offerings comprise custom synthesis (route design, target molecule synthesis, structure-based drug design, metabolite and impurity synthesis, GLP-compliant production for in vivo studies) and fee-for-service analytical chemistry using a Bruker Avance III 400 MHz NMR, Waters HPLC, PerkinElmer GC, Agilent FT-IR, and supporting instrumentation. AMT also incubates proprietary biotech programmes in organoboron pharmaceuticals and diagnostics, PEG linkers for antibody-drug conjugates, and AMPK activators.

AMT makes money through three distinct streams: (i) professional-service custom synthesis contracts with pharmaceutical, biotech, agricultural, and academic clients, (ii) one-time catalogue chemical product sales at unit prices typically ranging from approximately AUD $80 to $780 per pack, and (iii) usage-based analytical service fees starting at AUD $25 per 1H NMR sample. The company employs a sales-led direct go-to-market via its website, phone, and email, supplemented by an international channel partner network: Frontier Specialty Chemicals distributes AMT PEG products in the US (announced November 2025), Key Organics holds an exclusive European supply and marketing agreement under the BIONET brand (since September 2013), IDT Australia provides GMP manufacturing collaboration for clinical and commercial PEG linker supply (since December 2023), and Scaled Organics and AK Scientific act as additional distribution partners. End customers include pharmaceutical and biotechnology companies (primary segments), agricultural chemical firms, and academic and research institutions across Australia, North America, Europe, and Japan.

Advanced Molecular Technologies firmographics

Firmographics
Name
Advanced Molecular Technologies
Legal name
Advanced Molecular Technologies Pty Ltd
Website
https://amtechpl.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
Advanced Molecular Technologies (AMT) is a privately held Australian CRO and specialty chemical manufacturer offering custom organic synthesis, analytical services, and a catalogue of organoborons, PEG linkers, fluorophores, and ionisable lipids to pharmaceutical, biotech, agricultural, and academic clients globally.
Ownership category
akta.pro rank

Advanced Molecular Technologies industry classification

Industry
Product category
Contract Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (541380), Other Scientific and Technical Consulting Services (541690), Medical and Diagnostic Laboratories (62151)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYHLAGAHAH
Custom Intermediates & Advanced Intermediates Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Custom organic synthesis
  • Medicinal chemistry services
  • Specialty chemicals manufacturing
  • PEG linkers bioconjugation
  • Analytical chemistry services

Where Advanced Molecular Technologies is headquartered

Location

Headquarters

HQ city
Scoresby
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Advanced Molecular Technologies business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Custom Synthesis Contracts: AMT provides contract research and custom synthesis services to pharmaceutical, biotech, agricultural and academic institutions. Services include route design, target molecule synthesis, drug discovery, and process scale-up.
  2. Catalogue Chemical Product Sales: Sale of in-stock specialty chemicals including organoborons, organosilicons, nucleosides, halogenated organics, diaryls, catalysts, bioactives, PEG reagents and linkers, and fluorophores and dyes. Products are sold in various pack sizes with unit-based pricing.
  3. Analytical Services: Fee-for-service analytical testing including NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, Polarimetry, DSC, Flash Point, and Biotage Flash Purification. Samples from $25.00 AUD per 1H NMR.
  4. GMP Manufacturing Services: Through collaboration with IDT Australia, AMT supports the development and GMP manufacturing of polyethylene glycol (PEG) linkers for clinical and commercial supply.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goUnit pricing for catalogue chemical products
Usage-basedPay-as-you-goNMR analytical service pricing

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Advanced Molecular Technologies product offering

Product offering

Core offering

Advanced Molecular Technologies (AMT) is a contract research organisation and biotech incubator specialising in medicinal chemistry and custom organic synthesis. The company provides custom synthesis of target molecules, analytical chemistry testing services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC), and a catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, PEG linkers for ADCs, and fluorophores for pharmaceutical, biotech, agricultural and academic customers. AMT also supports GMP manufacturing of PEG linkers for clinical and commercial supply through its collaboration with IDT Australia.

Product overview

Advanced Molecular Technologies (AMT) operates as a biotech incubator and contract research organization (CRO) specializing in medicinal chemistry and custom organic synthesis. The company's portfolio combines core service offerings with a comprehensive catalog of specialty chemical products. Core services include Custom Organic Synthesis (route design, target molecule synthesis, GLP production for in vivo studies) and Analytical Services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC, flash point testing). The product catalog spans multiple chemical categories: General Chemicals, Organoborons, Organosilicons, Nucleosides, Halogenated Organics, Diaryls, Catalysts, Bioactives, PEG Reagents and Linkers (critical for antibody-drug conjugates and bioconjugate technologies), and Fluorophores and Dyes. AMT also incubates organoboron pharmaceuticals, diagnostics, PEG linkers for ADCs, and AMPK activators. Featured products include ionisable lipids such as Lipid 5, ALC-0315, and SM-102 used in advanced therapeutic modalities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Organic Synthesis Services Contract research service for custom synthesis of target molecules for pharmaceutical, biotech, and chemical markets. Includes route design, traditional synthesis of complex molecules, production of pharmacologically active reference compounds, structure-based drug design, scaffolds, building blocks, lead optimisation, and synthesis of metabolites, impurities and reference compounds, plus GLP-compliant compounds for in vivo studies.
  • Analytical Services Fee-for-service analytical chemistry testing including NMR (1H, 13C, 10B, 15N, 19F, 29Si, 31P), HPLC (NP/RP, chiral and achiral), GC, FT-IR, UV-Vis, Karl Fischer titration, Polarimetry, Thermogravimetric Analysis, DSC, Closed Cup Flash Point Testing, and Biotage SP4 Flash Purification. Targeted at pharmaceutical, biotech, academic and chemical industry customers.
  • GMP Manufacturing of PEG Linkers Managed-service GMP manufacturing collaboration with IDT Australia for development and production of polyethylene glycol (PEG) linkers. AMT contributes linker chemistry expertise, custom synthesis, process development and scale-up; IDT Australia provides GMP manufacturing, analytical testing, quality systems and regulatory support for clinical and commercial supply. Targeted at ADC developers across North America, Japan and other global pharmaceutical markets.
  • General Chemicals Catalogue Broad catalogue of general chemical compounds available for research and industrial applications, sold in various pack sizes with unit-based pricing.
  • Organoborons Catalogue Catalogue of organoboron compounds used in cross-coupling reactions and pharmaceutical research, sold in catalogue pack sizes (mg to g) with unit pricing.
  • Organosilicons Catalogue Catalogue of organosilicon compounds including HOMSi reagents for Hiyama cross-coupling reactions, sold with unit-based pricing.
  • Nucleosides Catalogue Catalogue of nucleoside compounds for pharmaceutical and biotech research applications, sold with unit-based pricing.
  • PEG Reagents and Linkers Catalogue Catalogue of polyethylene glycol (PEG) reagents and linkers for antibody-drug conjugates (ADCs), peptide conjugates, and bioconjugate technologies, available in catalogue and bulk quantities including GMP quality materials.
  • Fluorophores and Dyes Catalogue Catalogue of fluorescent probes and dyes for research and diagnostic applications, including products such as DBD-F (4-(N,N-Dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole).
  • Bioactives Catalogue Catalogue of biologically active compounds for pharmaceutical and biotech research, sold with unit-based pricing.
  • Halogenated Organics Catalogue Catalogue of halogenated organic compounds for synthesis and research applications, sold with unit-based pricing.
  • Diaryls Catalogue Catalogue of diaryl compounds for pharmaceutical and chemical research, sold with unit-based pricing.
  • Catalysts Catalogue Catalogue of catalytic compounds for organic synthesis reactions, sold with unit-based pricing.
  • ALC-0315 (AMTGC903-AL21) Featured ionisable lipid compound sold in 500mg ($310 AUD) and 1g ($470 AUD) pack sizes, used in lipid nanoparticle formulations for advanced therapeutics.
  • Lipid 5 (AMTGC1533-LP25) Featured ionisable lipid compound sold in 500mg ($390.00 AUD) and 1g ($595.00 AUD) pack sizes, used in lipid nanoparticle formulations for advanced therapeutics.
  • SM-102 (AMTGC936-SM21) Featured ionisable lipid compound for pharmaceutical applications, sold in 500mg ($420 AUD) and 1g ($680 AUD) pack sizes.

Companies that use Advanced Molecular Technologies

Customer profile

Segments4 records

Ideal customer profiles4 records

Advanced Molecular Technologies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Advanced Molecular Technologies partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Frontier Specialty ChemicalscoreChannel Partner/ Reseller/ Distributor · 20 November 2025Distribution partnership with Frontier Specialty Chemicals to enhance customer access to AMT's portfolio of high-purity functionalised PEGs for customers across the US. Frontier serves as a distribution and customer support partner, providing local sales, order management, and customer service. Inventory is located in the US to avoid customs delays. Products are available in catalogue and bulk quantities, as well as GMP quality materials.
  • IDT AustraliacoreStrategic or Co-development Partner · 22 December 2023Collaboration with IDT Australia to provide a streamlined pathway for the development and GMP manufacturing of polyethylene glycol (PEG) linkers. AMT contributes expertise in linker chemistry, custom synthesis, process development, and scale-up. IDT Australia provides GMP manufacturing capabilities, analytical testing, quality systems, and regulatory support for clinical and commercial supply. The collaboration supports customers across North America, Japan, and other global pharmaceutical markets.
  • Key OrganicscoreChannel Partner/ Reseller/ Distributor · 2 September 2013Exclusive European supply and marketing agreement. Key Organics distributes AMT products under its BIONET brand. Key Organics has an extensive range of over 65,000 screening compounds, intermediates, building blocks and biochemicals and access to global customer base within the global life sciences sector. Both companies collaborate to grow their differentiated technology and service offerings.
  • Scaled OrganicsminorChannel Partner/ Reseller/ DistributorListed as a distribution partner on AMT's partners page. Scaled Organics is a custom synthesis and chemical supply company.
  • AK ScientificminorChannel Partner/ Reseller/ DistributorListed as a distribution partner on AMT's partners page. AK Scientific is a custom synthesis and chemical supply company.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Advanced Molecular Technologies competitors and assessment

Company assessment

Direct peers

  • Enamine: Ukraine-based global supplier of building blocks, screening compounds, and custom synthesis services with a catalogue exceeding 250,000 compounds. Directly comparable to AMT as a catalogue-plus-custom-synthesis CRO serving pharma and academic customers.
  • Bide Pharmatech: China-based supplier of building blocks, intermediates, and custom synthesis services. Comparable to AMT as a custom synthesis CRO with an extensive catalogue, focused on pharma and biotech drug discovery customers.
  • PharmaBlock Sciences: China-headquartered provider of building blocks, intermediates, custom synthesis, and process R&D services to the pharmaceutical industry. Comparable to AMT across custom synthesis, building blocks, and reference compounds, with greater scale and GMP capacity.
  • Oakwood Chemical: US-based manufacturer and distributor of specialty organic chemicals, including fluorinated compounds, organometallics, and building blocks. Comparable to AMT as a catalogue chemistry supplier serving pharma, biotech, and academic customers.
  • Combi-Blocks: US-based supplier of chemical building blocks, screening compounds, and custom synthesis services for drug discovery. Directly comparable to AMT across catalogue building blocks, custom synthesis, and CRO services for pharmaceutical/biotech customers.
  • Key Organics: UK-based supplier of screening compounds, building blocks, intermediates, and biochemicals (65,000+ compounds under BIONET brand). Directly comparable as a catalogue chemistry and custom synthesis peer, and additionally serves as AMT's exclusive European distribution partner.

Broad incumbents

  • Alfa Aesar (Thermo Fisher Scientific): Global catalogue supplier of research chemicals, metals, and materials under Thermo Fisher Scientific. Overlaps with AMT's catalogue offerings (organics, building blocks, specialty chemicals) and serves the same pharma/biotech/academic customer base.
  • Sigma-Aldrich (Merck KGaA / MilliporeSigma): Global incumbent in research chemicals, analytical standards, and life science products. Overlaps with AMT's catalogue chemical business and analytical reagents, but at vastly greater scale and breadth across all research chemistries.
  • Tokyo Chemical Industry (TCI): Japan-based global supplier of organic chemicals, reagents, and custom synthesis services. Comparable to AMT across organics, organometallics, and catalogue chemistry, with a far larger catalogue and established international distribution.

Emerging players

  • Frontier Specialty Chemicals: US-based specialty chemicals distributor with focused PEG/bioconjugation product line. Comparable to AMT as a PEG-focused supplier to pharma/biotech, and additionally serves as AMT's US distribution partner for PEG products.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Advanced Molecular Technologies social profiles

Digital presence

Advanced Molecular Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Advanced Molecular Technologies leadership team

Management profile

Number of profiles

Advanced Molecular Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Advanced Molecular Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Molecular Technologies

What does Advanced Molecular Technologies do?

Advanced Molecular Technologies (AMT) is a contract research organisation and biotech incubator specialising in medicinal chemistry and custom organic synthesis. The company provides custom synthesis of target molecules, analytical chemistry testing services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC), and a catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, PEG linkers for ADCs, and fluorophores for pharmaceutical, biotech, agricultural and academic customers. AMT also supports GMP manufacturing of PEG linkers for clinical and commercial supply through its collaboration with IDT Australia.

Is Advanced Molecular Technologies a public or private company?

Advanced Molecular Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Advanced Molecular Technologies founded?

Advanced Molecular Technologies was founded in 2005. It employs 1 to 10 people.

Where is Advanced Molecular Technologies based?

Advanced Molecular Technologies is headquartered in Scoresby, Australia, in the Oceania region.

How does Advanced Molecular Technologies make money?

Four revenue lines are on record. Custom Synthesis Contracts are the primary driver. The others are catalogue Chemical Product Sales, analytical Services and GMP Manufacturing Services.

Who are Advanced Molecular Technologies's main competitors?

Direct peers on record are Enamine, Bide Pharmatech, PharmaBlock Sciences, Oakwood Chemical, Combi-Blocks and Key Organics. Broad incumbents are Alfa Aesar (Thermo Fisher Scientific), Sigma-Aldrich (Merck KGaA / MilliporeSigma) and Tokyo Chemical Industry (TCI). Frontier Specialty Chemicals is listed as an emerging player.

Does Advanced Molecular Technologies have an API?

No public API is recorded for Advanced Molecular Technologies.

What industry is Advanced Molecular Technologies in?

Advanced Molecular Technologies's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAHAH, Custom Intermediates & Advanced Intermediates Manufacturing, with a secondary code of HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales